BLAIR WILLIAM & CO/IL - BIODELIVERY SCIENCES INTL IN ownership

BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 86 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of BIODELIVERY SCIENCES INTL IN
ValueSharesWeighting
Q4 2021$1,436,000
-43.4%
463,083
-34.0%
0.01%
-44.4%
Q3 2021$2,535,000
-0.4%
702,143
-1.3%
0.01%0.0%
Q2 2021$2,546,000
-34.4%
711,236
-28.4%
0.01%
-40.0%
Q1 2021$3,882,000
-9.3%
992,769
-2.6%
0.02%
-6.2%
Q4 2020$4,281,000
+17.8%
1,019,177
+4.6%
0.02%
+6.7%
Q3 2020$3,635,000
-11.3%
974,533
+3.7%
0.02%
-25.0%
Q2 2020$4,098,000
+17.1%
939,954
+1.8%
0.02%
-9.1%
Q1 2020$3,500,000
-40.1%
923,526
-0.1%
0.02%
-26.7%
Q4 2019$5,844,000
+54.7%
924,755
+3.1%
0.03%
+36.4%
Q3 2019$3,778,000
-4.2%
897,345
+5.8%
0.02%
-4.3%
Q2 2019$3,943,000
-13.2%
847,920
-1.1%
0.02%
-17.9%
Q1 2019$4,545,000
+53.3%
857,595
+7.0%
0.03%
+27.3%
Q4 2018$2,965,000
+34.4%
801,470
+1.7%
0.02%
+57.1%
Q3 2018$2,206,000
+5.8%
787,845
+11.5%
0.01%0.0%
Q2 2018$2,085,000
+42.0%
706,870
+8.3%
0.01%
+40.0%
Q1 2018$1,468,000
-66.7%
652,525
-56.3%
0.01%
-66.7%
Q4 2017$4,402,000
-0.4%
1,492,355
-0.4%
0.03%
-9.1%
Q3 2017$4,421,000
+7.3%
1,498,597
+1.9%
0.03%
+6.5%
Q2 2017$4,119,000
+197.2%
1,471,122
+112.2%
0.03%
+181.8%
Q1 2017$1,386,000
+57.3%
693,181
+37.6%
0.01%
+37.5%
Q4 2016$881,000
-51.4%
503,697
-24.9%
0.01%
-50.0%
Q3 2016$1,811,000
+68.5%
670,797
+47.2%
0.02%
+60.0%
Q2 2016$1,075,000
-38.0%
455,718
-15.1%
0.01%
-37.5%
Q1 2016$1,734,000
-36.6%
537,003
-5.9%
0.02%
-38.5%
Q4 2015$2,734,000
-28.3%
570,903
-16.8%
0.03%
-21.2%
Q3 2015$3,815,000
-19.5%
686,223
+15.2%
0.03%
+371.4%
Q2 2015$4,739,000
-0.3%
595,461
+31.5%
0.01%0.0%
Q1 2015$4,755,000
+69.0%
452,875
+93.5%
0.01%
+40.0%
Q4 2014$2,813,000
-15.3%
234,065
+20.4%
0.01%
-16.7%
Q3 2014$3,321,000
+31.6%
194,365
-7.0%
0.01%
+50.0%
Q2 2014$2,523,000
+1271.2%
209,100
+857.0%
0.00%
Q1 2014$184,000
-12.8%
21,850
-39.1%
0.00%
Q4 2013$211,000
-55.5%
35,850
-58.9%
0.00%
-100.0%
Q3 2013$474,000
+21.2%
87,300
-9.4%
0.00%0.0%
Q2 2013$391,00096,4000.00%
Other shareholders
BIODELIVERY SCIENCES INTL IN shareholders Q3 2016
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,575,000$6,615,0004.38%
1492 Capital Management LLC 790,863$3,322,0001.91%
Rubric Capital Management LP 3,516,124$14,768,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,530,000$40,026,0000.79%
Zebra Capital Management LLC 144,241$606,0000.77%
KNOTT DAVID M 370,230$1,555,0000.70%
Nantahala Capital Management 5,123,671$21,519,0000.67%
SYSTEMATIC FINANCIAL MANAGEMENT LP 3,593,893$15,094,0000.66%
EMC Capital Management 98,933$416,0000.32%
ALGERT GLOBAL LLC 175,170$736,0000.21%
View complete list of BIODELIVERY SCIENCES INTL IN shareholders